Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

Elaheh Nasrollahzadeh1,2, Sepideh Razi2,3, Mahsa Keshavarz-Fathi2,4

  • 1School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Insights

Tumor-associated macrophages (TAMs) play a crucial role in cancer progression and metastasis by adopting diverse phenotypes within the tumor microenvironment (TME). Understanding TAM plasticity is key for developing novel cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • The tumor microenvironment (TME) is dynamic and influences cancer progression from initiation to metastasis.
  • Tumor-associated macrophages (TAMs) are key cellular components of the TME, exhibiting diverse and context-dependent phenotypes.
  • Traditional M1/M2 classification oversimplifies TAM functions, which are critical in shaping the TME.

Purpose of the Study:

  • To elucidate the multifaceted roles of TAMs in cancer progression and metastasis.
  • To highlight the phenotypic plasticity of TAMs in response to microenvironmental cues.
  • To underscore the therapeutic potential of targeting TAMs.

Main Methods:

  • Review of existing literature on TAM biology and function in cancer.
  • Analysis of TAM involvement across different stages of tumor evolution, including primary tumor formation, invasion, and pre-metastatic niche formation.
  • Discussion of TAM polarization and functional divergence within the TME.

Main Results:

  • TAMs contribute to early oncogenic mutations (M1-like) and promote tumor growth, angiogenesis, and immunosuppression (M2-like).
  • TAMs facilitate cancer cell invasion, intravasation, and the establishment of pre-metastatic niches.
  • TAMs are involved in shaping the primary, micro-invasive, and pre-metastatic TMEs.

Conclusions:

  • TAMs exhibit remarkable phenotypic plasticity, influenced by the TME, enabling them to support various stages of cancer progression.
  • The diverse functions of TAMs make them significant therapeutic targets for cancer treatment.
  • Targeting TAMs could offer novel strategies to inhibit tumor evolution and metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K